期刊文献+

特种蛋白检验项目室内质控方法的研究 被引量:2

Application of internal quality control procedures in special protein assays
原文传递
导出
摘要 目的评价特种蛋白检测项目的分析性能,优化质量控制方法。方法根据西格玛(σ)=[允许总误差(TEa)-偏倚(bias)]/变异系数(CV)公式,计算并评价每一检验项目的σ水平。另根据操作过程规范图(OPS图)选择最佳的质控方案,通过计算质量目标指数(QGI值)以判断优先改进精密度或准确度。结果按6σ标准IgG、IgA性能为优秀,IgM、C3为良好,C4为临界;依据OPS图法,当N=2时,IgG和IgA分别采用13s和13.5s/R4s/9X质控规则,其他三项均采用13s/22S/R4S/10X质控规则;误差检出概率(Ped)达到90%(C4为50%),假失控概率(Prf)要小于5%。根据QGI结果 ,5项特种蛋白检测方法均需要优先改进精密度。结论联合应用6σ方法和OPS图法对临床实验室进行质量控制是必要和可行的。 Aim To assess the performance of the special protein assays,then to optimize their internal quality control procedures. Method 1. Calculating and evaluating the sigma value with the equation σ=(TEa-bias)/ CV; 2. Selecting the best QC measurement and number with Operational Process Specifications (OPS); 3. Deciding the priority of improvement of imprecision or inaccuracy with Quality Goal Index (QGI). Results According to the standard of 6 sigma decision chart, the performance of IGG and IGA is excellent,IGM and C3 is good and C4 is borderline; Ped reaches to 90% ( C4:Ped reaches to 50%)and Pfr is less than 5%,which meet the request of clinic quality. The IGG and IGA assays apply 13s and 13.5s/R4s/9X (N=2)rule respectively according to OPS,when the others use 13s/22S/R4S/10X rule; The precision of each Special Protein assay should be improved first according to QGI. Conclusion The combination of Six Sigma methodology and OPS is an efficient and effective tool for quality management in clinical chemistry laboratory.
出处 《中国热带医学》 CAS 2010年第8期1011-1013,共3页 China Tropical Medicine
关键词 操作过程规范图 质量管理 Six Sigma Metric Operational Process Specifications Quality Management
  • 相关文献

参考文献5

  • 1申子瑜.医院管理学临床实验室管理分册[M].北京:人民卫生出版社,2003:74-77.
  • 2Alexander Bragat. Westgard QC A Six Sigma Method Decision Chart spreadsheet, www. westgard.com.
  • 3刘忠民 高月亭 陈涛 等.应用操作过程规范图评价和设计室内质量控制方法.医学实验室与临床,2007,14(4):17-20.
  • 4Coskun A . Six σand calculated laboratory tests [J] . Clin Chem, 2006,52(4) :770-771.
  • 5王治国.6σ质量标准在临床实验室质量控制的应用(Ⅰ)[J].上海医学检验杂志,2002,17(2):125-127. 被引量:78

共引文献100

同被引文献13

  • 1王丹丹,杨安岚,冼雄伟.临床生化室内质控失控情况及原因分析[J].中国热带医学,2007,7(8):1438-1439. 被引量:7
  • 2Ski'tek M. Acceptability limits based on biology goals in hematology EQAS[J]. Accred Qual Assur, 2005 (10):112-115.
  • 3Klee GG. Establishment of outcome-related analytic performance goals [J]. Clinical Chemistry, 2010, 56 (5) :714-722.
  • 4中国合格评定国家认可委员会.医学实验室质量和能力认可准则在临床免疫学检验领域的指南[S].中国合格评定国家认可委员会,CNAS-GL22:2008.
  • 5Howerton D, Krolak JM, Manasterski A, et al. Profi- ciency testing performance in US laboratories: re- sults reported to the Centers for Medicare Medi- caid 6ervices, 1994 through 2006[J]. Archives of Pa- thology &- Laboratory Medicine, 2010,134 (5) 751- 758.
  • 6中华人民共和国卫生部.临床生物化学检验常规项目分析质量指标[S].WS/T403-2012,中华人民共和国卫生部,2012.
  • 7SKITEK M. Acceptability limits based on biology goals in hematology EQAS [ J]. Accred Gual Assur, 2005, 10(3) :112-115.
  • 8KLEE GG. Establishment of outcome-related analytic performance goals [ J ]. Clin Chem, 2010, 56 ( 5 ) : 714-722.
  • 9孙虹,赵崇吉,王凡,牛华,刘琳,蒋红君,苏敏.以生物学变异为质量要求评价免疫球蛋白等项目的过程能力[J].检验医学,2010,25(9):737-739. 被引量:9
  • 10白玉,王治国,王薇,李少男,钟堃.全国常规化学检验项目室内质控变异系数的分析[J].检验医学,2011,26(3):207-209. 被引量:20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部